Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use
<p>Abstract</p> <p>Background</p> <p>Ipilimumab and vemurafenib have both been shown to improve survival in phase III trials of patients with metastatic melanoma. Although vemurafenib is associated with a rapid onset of activity, responses are often of limited duration. Conversely, responses to ipil...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2012-05-01
|
| Serie: | Journal of Translational Medicine |
| Soggetti: | |
| Accesso online: | http://www.translational-medicine.com/content/10/1/107 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|